Speaker

Zoran Rankovic, PhD

DIRECTOR, CBT CHEMISTRY CENTERS, ST. JUDE CHILDREN’S RESEARCH HOSPITAL
Zoran is director of chemistry at St Jude. Prior to joining St. Jude in late 2016, Zoran was medicinal chemistry director and research fellow in Organon, Schering-Plough, Merck and most recently Eli Lilly. During his industrial career Zoran directed teams that delivered clinical candidates over a range of therapeutic areas including oncology, neurodegeneration, psychiatry, and cardiovascular disorders. Zoran authored over 100 scientific publications, patents, and book chapters, and edited two books on drug discovery topics. Since joining St. Jude Zoran’s research interests focus on the development of small molecule epigenetic modulators and protein degraders for the treatment of pediatric cancers such as medulloblastoma and acute leukemia.
Speaking In
1:00 PM - 2:00 PM
Monday, June 5
Targeted protein degradation (TPD) is a hot area of drug discovery aiming to expand the universe of…